Research · 1 November 2026
Claude Sonnet 5 autonomously selects gene therapy and performs mouse brain surgery
Claude Sonnet 5 chose a gene therapy, target region, and injection parameters for an epileptic mouse, executed the surgery with a motorized device, and halted when a safety restriction triggered, refusing to bypass it.
Why it matters
Plan for fallback mechanisms; the agent’s self‑stop under safety limits shows the need for human‑override pathways.
For product managers
For your product
What does this mean for your product?
Try it on your product More from this issueAll AI news from 1 Nov →
Get this every morning, written for your product.
Deltaday reads the whole AI news cycle and tells you what changed, whether it's real yet, and what to do about it.